"Human health is shaped by the interactions between social and ecological systems. States of Disease advances a social ecology of health framework to demonstrate how historical spatial formations contribute to contemporary vulnerabilities to disease and the possibilities for health justice. The book examines how managed HIV in South Africa is being transformed with expanded access to antiretroviral therapy, and how environmental health in northern Botswana is shifting due to global climate change and flooding variability. These cases demonstrate how the political environmental context shapes the ways in which health is embodied, experienced, and managed"--Provided by publisher.

The United States is among the wealthiest nations in the world, but it is far from the healthiest. Although life expectancy and survival rates in the United States have improved dramatically over the past century, Americans live shorter lives and experience more injuries and illnesses than people in other high-income countries. The U.S. health disadvantage cannot be attributed solely to the adverse health status of racial or ethnic minorities or poor people: even highly advantaged Americans are in worse health than their counterparts in other, "peer" countries. In light of the new and growing evidence about the U.S. health disadvantage, the National Institutes of Health asked the National Research Council (NRC) and the Institute of Medicine (IOM) to convene a panel of experts to study the issue. The Panel on Understanding Cross-National Health Differences Among High-Income Countries examined whether the U.S. health disadvantage exists across the life span, considered potential explanations, and assessed the larger implications of the findings. U.S. Health in International Perspective presents detailed evidence on the issue, explores the possible explanations for the shorter and less healthy lives of Americans than those of people in comparable countries, and recommends actions by both government and nongovernment agencies and organizations to address the U.S. health disadvantage.

"The Nation has lost sight of its public health goals and has allowed the system of public health to fall into 'disarray'," from The Future of Public Health. This startling book contains proposals for ensuring that public health service programs are efficient and effective enough to deal not only with the topics of today, but also with those of tomorrow. In addition, the authors make recommendations for core functions in public health assessment, policy development, and service assurances, and identify the level of government--federal, state, and local--at which these functions would best be handled.

The Global Burden of Disease (GBD) provides systematic epidemiological estimates for an unprecedented 150 major health conditions. The GBD provides indispensable global and regional data for health planning, research, and education.

In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also contribute to health inequities, as well as the historic and ongoing interplay of structures, policies, and norms that shape lives. When these factors are not optimal in a community, it does not mean they are intractable: such inequities can be mitigated by social policies that can shape health in powerful ways. Communities in Action: Pathways to Health Equity seeks to delineate the causes of and the solutions to health inequities in the United States. This report focuses on what communities can do to promote health equity, what actions are needed by the many and varied stakeholders that are part of communities or support them, as well as the root causes and structural barriers that need to be overcome.

The only available reference to comprehensively discuss the common and unusual types of rickettsiosis in over twenty years, this book will offer the reader a full review on the bacteriology, transmission, and pathophysiology of these conditions. Written from experts in the field from Europe, USA, Africa, and Asia, specialists analyze specific patho

‘Mark Harrison's book illuminates the threats posed by infectious diseases since 1500. He places these diseases within an international perspective, and demonstrates the relationship between European expansion and changing epidemiological patterns. The book is a significant introduction to a fascinating subject.’ Gerald N. Grob, Rutgers State University In this lively and accessible book, Mark Harrison charts the history of disease from the birth of the modern world around 1500 through to the present day. He explores how the rise of modern nation-states was closely linked to the threat posed by disease, and particularly infectious, epidemic diseases. He examines the ways in which disease and its treatment and prevention, changed over the centuries, under the impact of the Renaissance and the Enlightenment, and with the advent of scientific medicine. For the first time, the author integrates the history of disease in the West with a broader analysis of the rise of the modern world, as it was transformed by commerce, slavery, and colonial rule. Disease played a vital role in this process, easing European domination in some areas, limiting it in others. Harrison goes on to show how a new environment was produced in which poverty and education rather than geography became the main factors in the distribution of disease. Assuming no prior knowledge of the history of disease, Disease and the Modern World provides an invaluable introduction to one of the richest and most important areas of history. It will be essential reading for all undergraduates and postgraduates taking courses in the history of disease and medicine, and for anyone interested in how disease has shaped, and has been shaped by, the modern world.

The Deadly Truth chronicles the complex interactions between disease and the peoples of America from the pre-Columbian world to the present. Grob's ultimate lesson is stark but valuable: there can be no final victory over disease. The world in which we live undergoes constant change, which in turn creates novel risks to human health and life. We conquer particular diseases, but others always arise in their stead. In a powerful challenge to our tendency to see disease as unnatural and its virtual elimination as a real possibility, Grob asserts the undeniable biological persistence of disease. Diseases ranging from malaria to cancer have shaped the social landscape--sometimes through brief, furious outbreaks, and at other times through gradual occurrence, control, and recurrence. Grob integrates statistical data with particular peoples and places while giving us the larger patterns of the ebb and flow of disease over centuries. Throughout, we see how much of our history, culture, and nation-building was determined--in ways we often don't realize--by the environment and the diseases it fostered. The way in which we live has shaped, and will continue to shape, the diseases from which we get sick and die. By accepting the presence of disease and understanding the way in which it has physically interacted with people and places in past eras, Grob illuminates the extraordinarily complex forces that shape our morbidity and mortality patterns and provides a realistic appreciation of the individual, social, environmental, and biological determinants of human health.

This title critically reviews old and new literature, help to create greater awareness of the disease in the US and helps in the evaluation of certain epidemiological and public health issues. During the first half of the 20th century, Chagas disease was assumed to be absent from the U.S. and considered an exotic disease, until the first two indigenous cases were discovered, almost simultaneously, in Texas, 1955. Since that time four indigenous cases have been documented in several places in the country. Although the disease is still considered uncommon in the US, this disease is not longer an exclusive Latin American illness. Physicians in the US are often unaware of the characteristics of the diseases, and are likely overlooking locally acquired cases. The influx of an estimated 300,000 Latin American immigrants with the Chagas parasite means that there is an urgent need for physicians and public health officials to become aware. Helps to create greater awareness of Chagas disease in the USA Helps to evaluate epidemiological and public health issues Facilitates accurate and necessary future public health interventions